TEMECULA, CA--(MARKET WIRE)--Jun 13, 2006 -- CLX Investment Company, Inc. (OTC BB:CLXN.OB - News) today announced that portfolio investment Zonda Inc., which specializes in diagnostic tests that serve the medical, bacterial food safety, cosmetic, beverage, pharmaceutical, veterinary, and environmental sanitation testing markets, has recently completed a new shipment of its HandiLab-C test for chlamydia to the United Kingdom. The shipment of HandiLab-C tests was sent to Zonda's distributor for pharmacies and other retail locations across the United Kingdom.
